Key result
Pretreatment with intraperitoneal DMSO significantly reduced cardiac damage from 18.75% to 4.46% (P<0.05) in a rat model of acute myocardial infarction.
Why the study?
Does intraperitoneal DMSO pretreatment reduce cardiac damage in a rat model of acute myocardial infarction?
Does intraperitoneal DMSO pretreatment reduce cardiac damage in a rat model of acute myocardial infarction?
Absolute Event Rate: 4.46% vs 18.75%
p-value: p=< 0.05
DMSO pretreatment significantly reduces cardiac damage and myocardial injury biomarkers in a rat model of acute myocardial infarction.
Hypothesis-generating for DMSO cardioprotection in rodent AMI; leaves open translation to human therapy.
Dimethyl sulfoxide (DMSO) is an organic compound widely used as solvent in biological studies and as vehicle for drug administration. DMSO has been shown to possess several biological effects, including antioxidant, anti-inflammatory, antinociceptive effects, and it has been proposed to be therapeutic in several disorders, such as gastrointestinal diseases, rheumatologic diseases, and for the treatment of several manifestations of amyloidosis. To better define the biological profile of DMSO, we investigated its effect on an in vivo model of acute myocardial infarction in rats, caused by left anterior descending coronary artery ligation. Our results show that pretreatment of rats with intraperitoneal (ip) DMSO (500 microL/Kg) for 3 consecutive days before left anterior descending coronary artery ligation significantly (P < 0.05) reduced cardiac damage from 18.75 +/- 4.88% (n = 12) to 4.46 +/- 2.01% (n = 8); serum levels of troponin I from 29.35 +/- 12.32 ng/mL (n = 8) to 2.95 +/- 1.32 ng/mL (n = 4); and serum levels of myoglobin from 46.86 +/- 10.35 ng/mL (n = 7) to 13.75 +/- 0.85 ng/mL (n = 4). Our data demonstrate that DMSO has a protective effect in a model of acute myocardial infarction in rats.
No takes yet. Share an insight, caveat, or question.
Parisi et al. (2010) studied Acute myocardial infarction (n=20). Dimethyl sulfoxide (DMSO) vs. Control was evaluated on Cardiac damage (p=< 0.05). Pretreatment with intraperitoneal DMSO significantly reduced cardiac damage from 18.75% to 4.46% (P<0.05) in a rat model of acute myocardial infarction.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: